265 related articles for article (PubMed ID: 12174154)
21. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
Muc-Wierzgon M; Nowakowska-Zajdel E; Zubelewicz B; Wierzgon J; Kokot T; Klakla K; Szkilnik R; Wiczkowski A
J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
[TBL] [Abstract][Full Text] [Related]
22. [Inhibitory effects of ligustrazine on the expression of intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1 in human umbilical vein endothelial cells induced by preeclamptic plasma].
Zeng S; Fan S; Jiang X
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):282-4. PubMed ID: 11775908
[TBL] [Abstract][Full Text] [Related]
23. [The significance of soluble vascular cell adhesion molecule-1 and its relationship with tumor necrosis factor-alpha and interferon-gamma in patients with pulmonary tuberculosis].
Liang Y; Dong DQ; Yang YH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):266-9. PubMed ID: 16750045
[TBL] [Abstract][Full Text] [Related]
24. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
25. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
Zhang D; Li J; Jiang Z; Yu B; Tang X
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1529-31. PubMed ID: 12609060
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
[TBL] [Abstract][Full Text] [Related]
27. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
Clin Chim Acta; 2011 Oct; 412(21-22):1957-62. PubMed ID: 21756887
[TBL] [Abstract][Full Text] [Related]
28. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
29. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
[TBL] [Abstract][Full Text] [Related]
30. TNF-receptor levels in preeclampsia--results of a longitudinal study in high-risk women.
Schipper EJ; Bolte AC; Schalkwijk CG; Van Geijn HP; Dekker GA
J Matern Fetal Neonatal Med; 2005 Nov; 18(5):283-7. PubMed ID: 16390786
[TBL] [Abstract][Full Text] [Related]
31. [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
Klimiuk PA; Sierakowski S; Fiedorczyk M; Chwiećko J
Przegl Lek; 2004; 61(2):86-9. PubMed ID: 15230147
[TBL] [Abstract][Full Text] [Related]
32. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
33. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM
Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
[TBL] [Abstract][Full Text] [Related]
34. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab.
Di Rocco P; Manco M; Rosa G; Greco AV; Mingrone G
Obes Res; 2004 Apr; 12(4):734-9. PubMed ID: 15090644
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of diurnal changes in serum concentration of TNF-alpha soluble receptors in gastrointestinal cancer patients.
Muc-Wierzgoń M; Baranowski MM; Madej K; Wierzgoń J; Kokot T; Brodziak A
J Biol Regul Homeost Agents; 2000; 14(3):204-8. PubMed ID: 11037054
[TBL] [Abstract][Full Text] [Related]
36. Raised serum TNF-alpha, blood sugar and uric acid in preeclampsia in third trimester of pregnancy.
Gulati R
JNMA J Nepal Med Assoc; 2005; 44(158):36-8. PubMed ID: 16554868
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
Iglesias J; Marik PE; Levine JS;
Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha is decreased in the umbilical cord plasma of patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Dollberg S; Socol ML
Am J Perinatol; 1999; 16(5):203-8. PubMed ID: 10535611
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
40. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
Jabłońska E; Pietruska Z
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
